v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
Previously Reported
Common Stock
Previously Reported
Additional Paid-in Capital
Previously Reported
Accumulated Deficit
Previously Reported
Stock Subscription Receivable
Previously Reported
Retroactive Application of Recapitalization
Common Stock
Retroactive Application of Recapitalization
Additional Paid-in Capital
Retroactive Application of Recapitalization
Accumulated Deficit
Retroactive Application of Recapitalization
Stock Subscription Receivable
Retroactive Application of Recapitalization
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Stock Subscription Receivable
Total
Balance at Dec. 31, 2023 $ 28,857,965 $ (25,445,506) $ 3,412,459 $ 6,980 $ (6,980) $ 6,980 $ 28,850,985 $ (25,445,506) $ 3,412,459
Balance (in Shares) at Dec. 31, 2023           1,396,000         1,396,000        
Net Income (loss)         (29,766,263)                   (32,535,982)
Balance at Mar. 31, 2024         (40,630,758)                   (40,630,758)
Balance at Dec. 31, 2023 28,857,965 (25,445,506) 3,412,459 $ 6,980 (6,980) $ 6,980 28,850,985 (25,445,506) 3,412,459
Balance (in Shares) at Dec. 31, 2023           1,396,000         1,396,000        
Net Income (loss)         (7,747,847)                   (10,621,556)
Balance at Jun. 30, 2024         (18,160,646)             82,483,948 (100,573,062) (80,241) (18,160,646)
Balance at Dec. 31, 2023 28,857,965 (25,445,506) 3,412,459 $ 6,980 (6,980) $ 6,980 28,850,985 (25,445,506) 3,412,459
Balance (in Shares) at Dec. 31, 2023           1,396,000         1,396,000        
Net Income (loss)         (14,384,526)                   (20,339,452)
Balance at Sep. 30, 2024         (18,786,644)             93,968,741 (110,290,958) (2,476,160) (18,786,644)
Balance at Dec. 31, 2023 28,857,965 (25,445,506) 3,412,459 $ 6,980 $ (6,980) $ 6,980 28,850,985 (25,445,506) 3,412,459
Balance (in Shares) at Dec. 31, 2023           1,396,000         1,396,000        
Capital contributions from related party                     487,273 487,273
Issuance of common stock upon consummation of the Merger                     $ 600 (27,888,519) (27,887,919)
Issuance of common stock upon consummation of the Merger (in Shares)                     120,093        
Conversion of convertible notes into common stock upon consummation of the Merger                     $ 596 3,174,404 3,175,000
Conversion of convertible notes into common stock upon consummation of the Merger (in Shares)                     119,245        
Stock subscription receivable                     (80,241) (80,241)
Shares issued from Earnout Arrangement                     63,600,000 (63,600,000)
Contingent consideration                     906,000 (906,000)
Convertible note – stock issuance loss                     2,805,678 2,805,678
Private Placements                     $ 1,735 12,930,262 12,931,997
Private Placements (in Shares)                     347,016        
Issuance costs in connection with the Private Placements                     (419,499) (419,499)
Shares issued from exercise of Series A Warrants                     $ 1,375 7,321,820 7,323,195
Shares issued from exercise of Series A Warrants (in Shares)                     274,858        
Shares issued from exercise of Series B Warrants                     $ 575 2,671,354 2,671,929
Shares issued from exercise of Series B Warrants (in Shares)                     114,992        
Issuance of common stock for Forward Purchase Agreement                     $ 954 3,123,425 (2,372,232) 752,147
Issuance of common stock for Forward Purchase Agreement (in Shares)                     190,860        
Issuance of common stock for Forward Purchase Agreement Compensation                     $ 285 1,025,715 1,026,000
Issuance of common stock for Forward Purchase Agreement Compensation (in Shares)                     57,000        
Forward Purchase Agreement – subscription receivable discount                     93,113 (93,113)
Stock-based compensation to consultants                     700,000 700,000
Shares issued to consultants                     $ 69 249,931 250,000
Shares issued to consultants (in Shares)                     13,892        
Stock-based compensation                     2,367,014 2,367,014
Net Income (loss)         (25,929,003)           (32,417,033) (32,417,033)
Balance at Dec. 31, 2024   93,045,581 (115,880,509) (80,241) (22,902,000)           $ 13,169 101,998,956 (122,368,539) (2,545,586) (22,902,000)
Balance (in Shares) at Dec. 31, 2024                     2,633,956        
Balance at Mar. 31, 2024         (40,630,758)                   (40,630,758)
Net Income (loss)         22,018,416             21,914,426 21,914,426
Balance at Jun. 30, 2024         (18,160,646)             82,483,948 (100,573,062) (80,241) (18,160,646)
Shares issued from exercise of Series A Warrants                       193,710 193,757
Net Income (loss)         (6,636,679)             (9,717,896) (9,717,896)
Balance at Sep. 30, 2024         (18,786,644)             93,968,741 (110,290,958) (2,476,160) (18,786,644)
Balance at Dec. 31, 2024   93,045,581 (115,880,509) (80,241) (22,902,000)           $ 13,169 101,998,956 (122,368,539) (2,545,586) (22,902,000)
Shares issued from exercise of Series A Warrants                     $ 74 241,472 241,546
Shares issued from exercise of Series A Warrants (in Shares)                     14,755        
Conversion of convertible notes into common stock                     $ 339 527,161 527,500
Conversion of convertible notes into common stock (in Shares)                     67,895        
Reverse stock split                     $ (13,311) 13,311
Shares issued to consultants                     $ 1 670 671
Shares issued to consultants (in Shares)                     100        
Stock-based compensation                     754,361 754,361
Net Income (loss)                     9,194,630 9,194,630
Balance at Mar. 31, 2025                     $ 272 103,535,931 (113,173,909) (2,545,586) (12,183,292)
Balance (in Shares) at Mar. 31, 2025                     2,716,706        
Balance at Dec. 31, 2024   $ 93,045,581 $ (115,880,509) $ (80,241) (22,902,000)           $ 13,169 101,998,956 (122,368,539) (2,545,586) (22,902,000)
Balance (in Shares) at Dec. 31, 2024                     2,633,956        
Shares issued from Earnout Arrangement                     $ 45 (45)
Shares issued from Earnout Arrangement (in Shares)                     450,000        
Shares issued from exercise of Series A Warrants                     $ 101 4,475,753 4,475,854
Shares issued from exercise of Series A Warrants (in Shares)                     280,287        
Conversion of convertible notes into common stock                     $ 339 527,161 527,500
Conversion of convertible notes into common stock (in Shares)                     68,095        
Reverse stock split                     $ (13,311) 12,851 (460)
Reverse stock split (in Shares)                     (112)        
Shares issued from Series C and D Warrant Conversion                     $ 343 43,030,159 43,030,502
Shares issued from Series C and D Warrant Conversion (in Shares)                     3,447,957        
Shares issuable upon settlement of warrants                     1,915,988 1,915,988
Forward Purchase Agreement – subscription receivable discount                     295,841 (295,841)
Stock-based compensation to consultants                     $ 36 3,821,086 3,821,122
Stock-based compensation to consultants (in Shares)                     345,100        
Stock-based compensation                     $ 24 2,949,896 2,949,920
Stock-based compensation (in Shares)                     240,000        
Net Income (loss)         $ (41,004,000)           (41,004,000) (41,004,000)
Balance at Dec. 31, 2025                     $ 746 159,027,646 (163,372,539) (2,841,427) (7,185,574)
Balance (in Shares) at Dec. 31, 2025                     7,465,283        
Balance at Mar. 31, 2025                     $ 272 103,535,931 (113,173,909) (2,545,586) (12,183,292)
Balance (in Shares) at Mar. 31, 2025                     2,716,706        
Net Income (loss)                       (2,113,859)  
Balance at Jun. 30, 2025                       103,738,980 (115,287,768) (2,545,586)  
Net Income (loss)                       (4,092,145)  
Balance at Sep. 30, 2025                       104,518,211 (119,379,913) (2,545,586)  
Balance at Dec. 31, 2025                     $ 746 159,027,646 (163,372,539) (2,841,427) (7,185,574)
Balance (in Shares) at Dec. 31, 2025                     7,465,283        
Shares issued upon settlement of warrants                     $ 24 (24)
Shares issued upon settlement of warrants (in Shares)                     240,400        
Forward Purchase Agreement – subscription receivable discount                     78,247 (78,247)
Discount on short term notes payable                     70,000 70,000
Stock-based compensation to consultants                     $ 4 (4)
Stock-based compensation to consultants (in Shares)                     40,000        
Stock-based compensation                     277,654 277,654
Net Income (loss)                     (1,430,668) (1,430,668)
Balance at Mar. 31, 2026                     $ 774 $ 159,453,519 $ (164,803,207) $ (2,919,674) $ (8,268,588)
Balance (in Shares) at Mar. 31, 2026                     7,745,683